Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies.

MLA

Guièze, Romain, et al. “Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies.” Cancer Cell, vol. 36, no. 4, Oct. 2019, p. 369. EBSCOhost, https://doi.org/10.1016/j.ccell.2019.08.005.

APA

Guièze, R., Liu, V. M., Rosebrock, D., Jourdain, A. A., Hernández-Sánchez, M., Martinez Zurita, A., Sun, J., Ten Hacken, E., Baranowski, K., Thompson, P. A., Heo, J.-M., Cartun, Z., Aygün, O., Iorgulescu, J. B., Zhang, W., Notarangelo, G., Livitz, D., Li, S., Davids, M. S., … Wu, C. J. (2019). Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies. Cancer Cell, 36(4), 369. https://doi.org/10.1016/j.ccell.2019.08.005

Chicago

Guièze, Romain, Vivian M Liu, Daniel Rosebrock, Alexis A Jourdain, María Hernández-Sánchez, Aina Martinez Zurita, Jing Sun, et al. 2019. “Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies.” Cancer Cell 36 (4): 369. doi:10.1016/j.ccell.2019.08.005.